The value of research from the subjects’ perspective — the survivors

While the pundits argue whether scientific research results are meaningful, other people are demonstrating the value of biomedical research in their own lives. Chronic myeloid leukemia used to have a fairly grim prognosis, but the early trials of the drug that became Gleevec showed that more favorable outcomes were possible. STAT recently published a roundup of interviews with some of the first clinical trials subjects to use what was then called STI571. See their stories here.